Repare Therapeutics Inc.
RPTX
$2.11
-$0.02-0.71%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -72.20M | -109.86M | -127.89M | -84.69M | -84.05M |
| Total Depreciation and Amortization | 2.75M | 3.15M | 2.61M | 1.92M | 1.97M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.42M | 9.74M | 18.61M | 20.38M | 20.99M |
| Change in Net Operating Assets | -4.12M | -6.37M | -10.83M | -14.06M | -16.19M |
| Cash from Operations | -70.15M | -103.34M | -117.51M | -76.45M | -77.28M |
| Capital Expenditure | -- | -- | -- | -- | -398.00K |
| Sale of Property, Plant, and Equipment | 1.00M | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 61.33M | 90.87M | 98.58M | 49.47M | 50.16M |
| Cash from Investing | 62.33M | 90.87M | 98.58M | 49.47M | 49.76M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 110.00K | 246.00K | 246.00K | 542.00K | 646.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 110.00K | 246.00K | 246.00K | 542.00K | 646.00K |
| Foreign Exchange rate Adjustments | -7.00K | 56.00K | -74.00K | -116.00K | 42.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -7.72M | -12.16M | -18.76M | -26.55M | -26.83M |